IGES Italy Pharma Consulting is part of the IGES Group, a leading European research and consulting organization in business and access strategy, pricing and reimbursement (P&R), HTA and patient access founded in 1980. Headquartered in Berlin, with local teams in Italy, France, Spain, and Germany and partnerships in other EU countries (e.g., Nordics), IGES combines deep local insights with a strong European footprint. Its multidisciplinary and multilingual experts work synergistically across Member States, supporting informed, data-driven access and business decisions. IGES is very active in EU initiatives aimed at strengthening collaboration and evidence-based approaches to healthcare decision-making. The Group has contributed to projects such as EUnetHTA 2021 and continues to support pharmaceutical and biotech companies in developing their Joint Clinical Assessment (JCA) strategies under the EU HTA Regulation. Through these activities, IGES works closely with EU institutions, national authorities, payers, and industry stakeholders to promote greater alignment, affordability, and transparency in medicines access. With robust experience in data analysis, access monitoring, and launch strategy, IGES provides evidence-based solutions at both national and EU levels. Combining IGES Italy’s local depth with IGES Group’s EU-wide expertise, the organization stands as a trusted partner to advance patient access and affordability across Europe. IGES Italy highly engages in mentorship and investor readiness activities offered to existing and upcoming startup across the EU, from the business model definition, product development roadmap, pricing/early HTA and market access strategy, until the business plan development and investor readiness preparation.